Association between a microRNA binding site polymorphism in SLCO1A2 and the risk of delayed methotrexate elimination in Chinese children with acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Association between a microRNA binding site polymorphism in SLCO1A2 and the risk of delayed methotrexate elimination in Chinese children with acute lymphoblastic leukemia

Published:2018-02 Issue: Volume:65 Page:61-66
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Wang Shu-mei,Zeng Wei-xin,Wu Wan-shui,Sun Lu-lu,Yan Dan

Funder

National Natural Science Foundation of China

Beijing Municipal Administration of Hospitals’ Youth Programme

Beijing Key Laboratory of Bio-characteristic Profiling for Evaluation of Rational Drug Use

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference37 articles.

1. The pharmacology and clinical use of methotrexate;Jolivet;N. Engl. J. Med.,1983

2. Treatment of childhood acute lymphoblastic leukemia;Stanulla;Semin. Hematol.,2009

3. Advances in individual prediction of methotrexate toxicity: a review;Schmiegelow;Br. J. Haematol.,2009

4. Maintenance chemotherapy for childhood acute lymphoblastic leukemia: relation of bone-marrow and hepatotoxicity to the concentration of methotrexate in erythrocytes;Schmiegelow;Cancer Chemother. Pharmacol.,1989

5. Prognostic significance of hepatotoxicity during maintenance chemotherapy for childhood acute lymphoblastic leukaemia;Schmiegelow;Br. J. Cancer,1990

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of genetic variants in the solute carrier (SLC) genes encoding drug uptake transporters on the response to anticancer chemotherapy;Cancer Drug Resistance;2024-07-18

2. Systematic review: genetic polymorphisms in the pharmacokinetics of high-dose methotrexate in pediatric acute lymphoblastic leukemia patients;Cancer Chemotherapy and Pharmacology;2024-07-13

3. Risk factors associated with high-dose methotrexate induced toxicities;Expert Opinion on Drug Metabolism & Toxicology;2024-03-19

4. Association of microRNA Polymorphisms with Toxicities Induced by Methotrexate in Children with Acute Lymphoblastic Leukemia;Hematology Reports;2023-11-20

5. Impact of microRNA polymorphisms on high-dose methotrexate-related hematological toxicities in pediatric acute lymphoblastic leukemia;Frontiers in Pediatrics;2023-06-13